Status:
UNKNOWN
Low Dose Radiotherapy for COVID-19 Pneumonitis
Lead Sponsor:
Hospital San Carlos, Madrid
Conditions:
Covid19
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
SARS-CoV-2 is causing an unprecedented stress on healthcare systems around the world, due to its high rate of infection and the high morbidity and mortality. The COVID-19 infection triggers an inflam...
Eligibility Criteria
Inclusion
- Age ≥ 60 years.
- COVID19 + confirmed by PCR.
- Thoracic imaging study (chest X-ray, chest CT or PET-CT), compatible with lung involvement.
- Phase II or lung phase without any improvement with pharmacological treatment.
- Phase III or hyper-inflammatory phase without any improvement with pharmacological treatment
- Poor clinical and functional respiratory evolution: \> 30 breaths / minute, SpO2 \<93%, PaO2 / FiO2 \<300.
- D-dimer\> 1000 ng / mL or rising, ferritin\> 1000 ng / mL, PCR\> 10 mg / dL or double than before.
Exclusion
- 1\. Severe comorbidities that could hamper the radiation treatment.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 8 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04420390
Start Date
May 1 2020
End Date
September 8 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Oncología Radioterápica. Hospital Clínico San Carlos
Madrid, Spain, 28040